Literature DB >> 16013667

Human tissue kallikreins: from gene structure to function and clinical applications.

George M Yousef1, Christina V Obiezu, Liu-Ying Luo, Angeliki Magklara, Carla A Borgoño, Tadaaki Kishi, Nader Memari, lacovos P Michael, Michael Sidiropoulos, Lisa Kurlender, Katerina Economopolou, Carl Kapadia, Nahoko Komatsu, Constantina Petraki, Marc Elliott, Andreas Scorilas, Dionyssios Katsaros, Michael A Levesque, Eleftherios P Diamandis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16013667     DOI： 10.1016/s0065-2423(04)39002-5

Source DB:  PubMed          Journal:  Adv Clin Chem        ISSN： 0065-2423            Impact factor:   5.394


× No keyword cloud information.
  12 in total

1.  The miRNA-Kallikrein interactions: adding a new dimension.

Authors:  Maria D Pasic; Georgia Sotiropoulou; George M Yousef
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Expression of Kallikrein-Related Peptidase 6 in Primary Mucosal Malignant Melanoma of the Head and Neck.

Authors:  Julia Thierauf; Johannes A Veit; Jochen K Lennerz; Stephanie E Weissinger; Annette Affolter; Johannes Döscher; Christoph Bergmann; Andreas Knopf; Jennifer Grünow; Lisa Grünmüller; Cornelia Mauch; Peter K Plinkert; Thomas K Hoffmann; Jochen Hess
Journal:  Head Neck Pathol       Date:  2016-11-14

3.  Serum human kallikrein 7 represents a new marker for cervical cancer.

Authors:  Weiwei Li; Yi Zhao; Lina Ren; Xin Wu
Journal:  Med Oncol       Date:  2014-09-03       Impact factor: 3.064

4.  Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer.

Authors:  N M A White; T-F F Chow; S Mejia-Guerrero; M Diamandis; Y Rofael; H Faragalla; M Mankaruous; M Gabril; A Girgis; G M Yousef
Journal:  Br J Cancer       Date:  2010-03-30       Impact factor: 7.640

5.  Prognostic significance of human tissue kallikrein-related peptidases 11 and 15 in gastric cancer.

Authors:  David L Kolin; Keiyan Sy; Fabio Rotondo; Mena N Bassily; Kalman Kovacs; Christine Brezden-Masley; Catherine J Streutker; George M Yousef
Journal:  Tumour Biol       Date:  2015-07-30

6.  KLK6-regulated miRNA networks activate oncogenic pathways in breast cancer subtypes.

Authors:  Konstantinos G Sidiropoulos; Qiang Ding; Georgios Pampalakis; Nicole M A White; Peter Boulos; Georgia Sotiropoulou; George M Yousef
Journal:  Mol Oncol       Date:  2016-04-08       Impact factor: 6.603

7.  Kallikreins 5, 6 and 10 differentially alter pathophysiology and overall survival in an ovarian cancer xenograft model.

Authors:  David Pépin; Zhong-Qi Shao; Geneviève Huppé; Andrea Wakefield; Chee-Wui Chu; Zahra Sharif; Barbara C Vanderhyden
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

8.  Identification of human tissue kallikrein 6 as a potential marker of laryngeal cancer based on the relevant secretory/releasing protein database.

Authors:  Ying Zhang; Zaixing Zhang; Lei Yang; Bin Xu; Weihua Li; Pingzhang Tang; Zongmin Zhang; Naijun Han; Yanning Gao; Shujun Cheng; Ting Xiao
Journal:  Dis Markers       Date:  2014-02-11       Impact factor: 3.434

9.  Expression of kallikrein-related peptidase 7 is decreased in prostate cancer.

Authors:  Chong-Yu Zhang; Yu Zhu; Wen-Bin Rui; Jun Dai; Zhou-Jun Shen
Journal:  Asian J Androl       Date:  2015 Jan-Feb       Impact factor: 3.285

10.  NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells.

Authors:  Jiajia Hu; Hu Lei; Xiaochun Fei; Sheng Liang; Hanzhang Xu; Dongjun Qin; Yue Wang; Yingli Wu; Biao Li
Journal:  Sci Rep       Date:  2015-11-30       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.